Despite what the name suggests, Polycystic Ovary Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PCOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.
At its core, PCOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PCOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PCOS so challenging—and why understanding your unique experience matters.
So, how can the PCOS Association help?
We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PCOS—and make progress.
Here’s what you’ll find at PCOSA:
✅ Reliable, science-backed information about what PCOS is (and isn’t)
💬 Supportive communities of people who understand exactly what you’re going through
🧬 Resources for navigating fertility, metabolic health, nutrition, and more
🧠 Education for providers who want to better support their PCOS patients
🙋♀️ Advocacy to make sure PCOS is recognized, researched, and respected
No fluff. No fad cures. Just real support, grounded in evidence and compassion.
At PCOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.
pcos: Latest results from PubMed
Background/Objectives: Sexual health is shaped by lifestyle factors alongside biomedical determinants. This review synthesises evidence on physiotherapy, balneology/peloidotherapy, and diet therapy as preventive and therapeutic adjuncts for female sexual dysfunctions and related gynaecological conditions. Methods: A structured narrative review of PubMed and Google Scholar (June-July 2025) was conducted by three independent reviewers using predefined keywords in English and Polish. Case reports,...
Published on: Sat, 10 Jan 2026 06:00:00 -0500
Authors: Agata Puszcz, Paulina Kozłowska, Justyna Wójcik, Anna Morawska, Małgorzata Wójcik, Katarzyna Plagens-Rotman, Monika Englert-Golon, Jakub Mroczyk, Małgorzata Mizgier, Ewa Jakubek, Magdalena Pisarska-Krawczyk, Stefan Sajdak, Klaudyna Madziar, Witold Kędzia, Grażyna Jarząbek-Bielecka,
Metabolic syndrome (MetS) and its associated conditions, namely, type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), obesity, and polycystic ovary syndrome (PCOS) are characterized by insulin resistance, dyslipidemia, and low-grade inflammation. Curcumin, a polyphenolic compound derived from Curcuma longa Linn., exhibits pleiotropic metabolic and anti-inflammatory properties and has thus been evaluated as a nutraceutical intervention for these conditions, but findings...
Published on: Sat, 10 Jan 2026 06:00:00 -0500
Authors: Samuel Abiodun Kehinde, Zahid Naeem Qaisrani, Rinrada Pattanayaiying, Bo Bo Lay, Khin Yadanar Phyo, Wai Phyo Lin, Myat Mon San, Nurulhusna Awaeloh, Sasithon Aunsorn, Ran Kitkangplu, Sasitorn Chusri,
The aim of this study was to examine associations involving serum proprotein convertase subtilisin/kexin type 9 (PCSK9) in metabolic disturbances observed in women with polycystic ovary syndrome (PCOS), with particular emphasis on the potential impact of tobacco smoke exposure. The study included 88 women: 60 with PCOS (23 smokers and 37 non-smokers) and 28 without PCOS. Selected biochemical and molecular biomarkers related to lipid metabolism, oxidative stress, and inflammation were assessed....
Published on: Sat, 10 Jan 2026 06:00:00 -0500
Authors: Justyna Niepsuj, Agnieszka Piwowar, Grzegorz Franik, Anna Bizoń,
The in vitro maturation (IVM) of human oocytes represents a valuable assisted reproductive technology that bypasses the need for full ovarian stimulation, offering safer alternatives for patients with polycystic ovary syndrome (PCOS), resistant ovary syndrome, or those requiring fertility preservation before oncological treatment. Despite its potential, IVM efficiency remains lower than that of conventional in vitro fertilization (IVF) due to incomplete understanding of the molecular and...
Published on: Sat, 10 Jan 2026 06:00:00 -0500
Authors: Marta Gargallo-Alonso, Helen M Picton, Clara Malo,
Background: Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder characterized by hyperandrogenism, ovulatory dysfunction, and an increased prevalence of metabolic syndrome. Clusterin (CLU), a chaperone protein induced by cellular stress and known to play roles in inflammation, oxidative stress, and lipid metabolism, may be associated with the metabolic abnormalities observed in patients with PCOS. The purpose of this current study is to investigate serum CLU levels and...
Published on: Sat, 10 Jan 2026 06:00:00 -0500
Authors: Dilara Sarıkaya Kurt, Recep Taha Ağaoğlu, Mehmet Ferdi Kıncı, Tuğçe Sırma, Ahmet Kurt, Ramazan Erda Pay, İsmail Burak Gültekin, Hüseyin Levent Keskin, Sezin Ertürk Aksakal,
Background and Clinical Significance: Anti-Müllerian hormone (AMH) is a dimeric glycoprotein secreted from the granulosa cells of the preantral and small antral follicles, which has entered routine clinical practice as a valuable tool for the diagnosis of different ovarian disorders. Increased AMH levels have been recommended as a criterion for polycystic ovary syndrome (PCOS). However, its widespread use remains limited due to analytical diversity and contradictory age-specific thresholds,...
Published on: Sat, 10 Jan 2026 06:00:00 -0500
Authors: Ralitsa Robeva, Tzvetozar Mehandjiev, Roumen Dimitrov, Yuri Hranov, Silvia Andonova, Mihaela Mladenova, Atanaska Elenkova, George Hadjidekov, Sabina Zacharieva,
Endometrial hyperplasia (EH) comprises a spectrum of abnormal proliferative changes in the endometrium, ranging from benign glandular overgrowth to lesions with substantial malignant potential. The importance of risk stratification and early identification is highlighted by the growing recognition of EH as a precursor to endometrial cancer. The main causes of EH, according to epidemiological research, include obesity, polycystic ovarian syndrome (PCOS), metabolic dysfunction, and extended...
Published on: Sat, 10 Jan 2026 06:00:00 -0500
Authors: Apostolia Galani, Sofoklis Stavros, Efthalia Moustakli, Anastasios Potiris, Athanasios Zikopoulos, Ismini Anagnostaki, Konstantinos Zacharis, Maria Paraskevaidi, Deirdre Lyons, Stefania Maneta-Stavrakaki, Nikolaos Thomakos, Maria Kyrgiou, Ekaterini Domali,
CONCLUSIONS: Acupuncture therapy offers potential therapeutic benefits to PCOS women, with mechanisms involving the bile acid-FXR axis potentially contributing to improvements in insulin resistance and other disease-related symptoms.
Published on: Sat, 10 Jan 2026 06:00:00 -0500
Authors: Haolin Zhang, Yang Chen, Dai Heng, Jingzhi Luo, Haining Wang, Wei Wang, Zejun Huo, Rui Wei, Yang Ye, Xiaoyu Long, Chunmei Zhang, Wen Ma, Li Shi, Yang Yang, Chunhua Shan, Shuhan Yang, Rong Li, Dong Li, Jie Qiao,
Polycystic ovary syndrome (PCOS) is characterized by reproductive and metabolic dysfunction that may also impact bone metabolism and its structural integrity. This study aims to assess the progressive impact of PCOS on bone health over time. It focuses on how the duration of the condition influences hormonal profiles, bone metabolism, its microstructural and mechanical properties in the PCOS-induced mice model. Female BALB/c mice are separated into three groups, each further subdivided into PCOS...
Published on: Fri, 09 Jan 2026 06:00:00 -0500
Authors: Sarita Pandey, Saroj Kumar, Madhu Gupta, Shweta Shukla, Ramesh Chaurasiya, Hina Masroor, Aditi Singh, Navin Kumar, Md Arshad,
Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder often presenting with menstrual irregularities, hyperandrogenism, and metabolic dysfunction. Hyperprolactinemia, characterized by elevated prolactin levels, may share overlapping features with PCOS and complicate diagnosis. When these two conditions coexist, they present unique clinical and management challenges. A 25-year-old woman with a history of PCOS presented with amenorrhea, progressive weight gain, and irregular...
Published on: Fri, 09 Jan 2026 06:00:00 -0500
Authors: Olabosipo Sholuade, Goodness Njoku, Suma Kaza, Reshma A Fatteh, Manoj Kollukkad, Charles Edwards,
CONCLUSION: These results suggest that C. olitorius leaves ameliorate PCOS symptoms in the studied biochemical and histological parameters.
Published on: Fri, 09 Jan 2026 06:00:00 -0500
Authors: Udoh Ekaette Sunday, Essiet Grace Akanimo, Victor Udo Nna, Umoren Inyang Arit, Ugbem Theophilius Ipeh, Lapeh Pierre Takem, Umiom Edem,
Overweight or obese women with polycystic ovary syndrome (PCOS) frequently exhibit metabolic disturbances and reproductive dysfunction. This systematic review and meta-analysis evaluated the efficacy and safety of liraglutide in improving metabolic and reproductive outcomes in this population. PubMed, Embase, the Cochrane Library, Scopus, Web of Science and ClinicalTrials.gov were systematically searched from inception to 31 May 2025 for randomized controlled trials (RCTs) comparing liraglutide...
Published on: Fri, 09 Jan 2026 06:00:00 -0500
Authors: Yu-Ting Lu, Po-Han Chang, Hsuan-Ju Chen, Ya-Wen Hsueh, Chia-Wei Chang, Hsi-Chen Hsu, Tung-Chuan Yang, Wu-Chou Lin, Hsun-Ming Chang,
CONCLUSION: TVOD appears to have positively impacted the yield of transferable embryos and euploid embryos in patients with PCOS when compared to a well-matched control.
Published on: Thu, 08 Jan 2026 06:00:00 -0500
Authors: Moses Bibi, Sarah Rubin, Kaleb Noruzi, Rachel Stern, Shmuel Sashitzky, Adi Steinhart, Martin D Keltz,
CONCLUSION: Metformin appears to have some benefits for adolescents with PCOS, offering some metabolic and menstrual benefits based on a small number of observational studies and small RCTs. SPIOMET and flutamide & metformin show superior, multi-domain efficacy but should be studied in larger RCTs. Critical gaps include adolescent-specific GLP-1RA data and standardised outcome measures to guide optimal non-hormonal strategies.
Published on: Thu, 08 Jan 2026 06:00:00 -0500
Authors: Rhea Sibal, Morgan Keogh, Pallavi Latthe, Jan Idkowiak,
CONCLUSION: Women with PCOS remain at high risk for NCDs (CVD, diabetes, endometrial cancer, OSA), yet experience substantial gaps in risk awareness, monitoring, and counseling. Addressing these deficiencies through improved clinical practice, education and adopting holistic PCOS management that balances NCD prevention with infertility concerns, is essential for safeguarding long-term health.
Published on: Thu, 08 Jan 2026 06:00:00 -0500
Authors: Susanne Theis, Elena Pavicic, Julia Estermann, Norman Bitterlich, Hamideh Frühwein, Petra Stute,